A 'mild' COVID-19 case just means you don't end up in the hospital, epidemiologists caution
There was good news and bad news about COVID-19 and its Omicron variant on Tuesday.
U.S. health officials said the new variant is spreading fast and will soon become the dominant coronavirus strain in the U.S., demoting Delta, but Pfizer announced that its new antiviral drug Paxlovid has proved extremely effective at keeping high-risk COVID-19 patients alive and out of the hospital, and appears to work against the Omicron variant. A South African study found that two doses of Pfizer's vaccine was only 33 percent effective against Omicron infection and 70 percent effective at preventing hospitalization and death, but also that the illness from this new variant appears more mild than with previous strains.
Even if Omicron proves to be more mild, "'mild' doesn't mean 'no big deal,'" Joanne Kenen cautions in Politico's Nightly newsletter. "Mild Covid-19 can still cause a whole lot of illness, a whole lot of economic disruption, a whole lot of strain on health care systems around the world." For one thing, if the new variant were 75 percent less deadly than previous strains but infected four times as many people, "the same number of lives would be lost," she notes. And for people who recover, nobody knows about Omicron and lingering long-COVID symptoms.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Also, "'mild' to an epidemiologist doesn't mean the same thing that 'mild' indicates to you and me," Kenen adds. "Mild to us means not feeling so bad. Mild to the public health professional just means you aren't in the hospital."
A virus "can knock you off your feet and debilitate you for a few days and we'd still call it mild," said Marcus Plescia, chief medical officer at the American Society of State and Territorial Health Officials. "Mild" covers everything from the sniffles to being bedridden with fever and aches, adds Megan Ranney, an emergency physician at Brown University. "Even if I don't get super-sick, thanks to the vaccines," she told Nightly, "I can't afford to take 10 days off of work." Read more at Politico.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Ecuador's cloud forest has legal rights – and maybe a song credit
Under the Radar In a world first, 'rights of nature' project petitions copyright office to recognise Los Cedros forest as song co-creator
By Harriet Marsden, The Week UK Published
-
Today's political cartoons - November 3, 2024
Cartoons Sunday's cartoons - presidential pitching, wavering convictions, and more
By The Week US Published
-
Why Man United finally lost patience with ten Hag
Talking Point After another loss United sacked ten Hag in hopes of success in the Champion's League
By The Week UK Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published